(Q44183076)

30 November 2017

Pharmacogenetic evidence that cd36 is a key determinant of the metabolic effects of pioglitazone (English)

1 reference

30 November 2017

Nianning Qi

1

1 reference

30 November 2017

Ludmila Kazdova

2

1 reference

30 November 2017

Vaclav Zidek

3

1 reference

30 November 2017

Vladimir Landa

4

1 reference

30 November 2017

Vladimir Kren

5

1 reference

30 November 2017

Harrihar A Pershadsingh

6

1 reference

30 November 2017

Elizabeth St Lezin

7

1 reference

30 November 2017

Nada A Abumrad

8

1 reference

30 November 2017

Michal Pravenec

9

1 reference

30 November 2017

Theodore W Kurtz

10

1 reference

30 November 2017

language of work or name

English

0 references

publication date

15 October 2002

1 reference

Journal of Biological Chemistry

30 November 2017

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

30 November 2017

277

1 reference

30 November 2017

50

1 reference

30 November 2017

48501-48507

1 reference

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

30 November 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206655200

Peroxisome proliferator-activated receptors: from genes to physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206655200

Comprehensive messenger ribonucleic acid profiling reveals that peroxisome proliferator-activated receptor gamma activation has coordinate effects on gene expression in multiple insulin-sensitive tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206655200

The mechanisms of action of PPARs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206655200

Thiazolidinedione treatment prevents free fatty acid-induced insulin resistance in male wistar rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206655200

PPARgamma activators improve glucose homeostasis by stimulating fatty acid uptake in the adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206655200

Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206655200

Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: comparison with PPAR-gamma activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206655200

Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206655200

Free fatty acids, insulin resistance, and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206655200

Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206655200

Disordered metabolism in diabetes: have we underemphasized the fat component?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206655200

Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206655200

Expression of the CD36 homolog (FAT) in fibroblast cells: effects on fatty acid transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206655200

PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206655200

CD36 deficiency associated with insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206655200

Genetics of Cd36 and the clustering of multiple cardiovascular risk factors in spontaneous hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206655200

Transgenic rescue of defective Cd36 ameliorates insulin resistance in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206655200

Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206655200

Defective fatty acid uptake in the spontaneously hypertensive rat is a primary determinant of altered glucose metabolism, hyperinsulinemia, and myocardial hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206655200

Troglitazone action is independent of adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206655200

Resistin and obesity-associated insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206655200

Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206655200

Regulation of FAT/CD36 gene expression: further evidence in support of a role of the protein in fatty acid binding/transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206655200

21 January 2018

Identifiers

DOI

10.1074/JBC.M206655200

1 reference

30 November 2017

1 reference